Evidence map›Paper›PMID 27348849›Full record

ArticleBiomaterials2016

Aligned nanofibrillar collagen scaffolds - Guiding lymphangiogenesis for treatment of acquired lymphedema.

Catarina Hadamitzky, Tatiana S Zaitseva, Magdalena Bazalova-Carter, Michael V Paukshto, Luqia Hou, Zachary Strassberg, James Ferguson, Yuka Matsuura, Rajesh Dash, Phillip C Yang and 5 more

Open access · greenAbstract read
In one paragraph

Article in Biomaterials, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 2 syntheses or guidelines pooled it, 86 citations in OpenAlex.

  1. Biomaterials in the clinical treatment of lymphedema-a systematic review.Journal of vascular surgery. Venous and lymphatic disorders · 2024
    Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Understanding the Lymphatic System: Tissue-on-Chip Modeling.Annual review of biomedical engineering · 2025
    Review
  15. Article
  16. Review
  17. Article
  18. Biomaterial-Based Therapeutic Delivery of Immune Cells.Advanced healthcare materials · 2025
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 3 countries.

Catarina HadamitzkyClinic of Plastic, Esthetic and Hand Surgery, Helios Clinic Hildesheim, Hildesheim 31135, Germany.
Tatiana S ZaitsevaFibralign Corporation, Union City, California 94587, USA.
Magdalena Bazalova-CarterDepartment of Radiation Oncology, Stanford University, Stanford, California 94305, USA.
Michael V PaukshtoFibralign Corporation, Union City, California 94587, USA.
Luqia HouStanford Cardiovascular Institute, Stanford University, Stanford, California 94305, USA.
Zachary StrassbergCenter for Tissue Regeneration, Repair and Restoration, Veterans Affairs Palo Alto Health Care System, Palo Alto, California 94304, USA.
James FergusonSurpass Inc., Mountain View, California 94043, USA.
Yuka MatsuuraDivision of Cardiovascular Medicine, Stanford University, Stanford, California 94305, USA.
Rajesh DashDivision of Cardiovascular Medicine, Stanford University, Stanford, California 94305, USA.
Phillip C YangDivision of Cardiovascular Medicine, Stanford University, Stanford, California 94305, USA.
Shura KretchetovIntraOp Medical Corporation, Sunnyvale, California 94085, USA.
Peter M VogtClinic of Plastic, Hand and Reconstructive Surgery, Hannover Medical School, Hannover 30625, Germany.
Stanley G Rockson *Division of Cardiovascular Medicine, Stanford University, Stanford, California 94305, USA.
John P Cooke *Division of Cardiovascular Medicine, Stanford University, Stanford, California 94305, USA.
Ngan F Huang *Stanford Cardiovascular Institute, Stanford University, Stanford, California 94305, USA.
Cardiovascular Institute of the South · USVA Palo Alto Health Care System · USFibralign (United States) · USCCS Associates (United States) · USHouston Methodist · USInfinera (United States) · USMedizinische Hochschule Hannover · DEUniversity of Hildesheim · DEUniversity of Victoria · CA

Funding

Aligned Nanofibrillar Scaffolds Enhance Angiogenesis and Viability in Ischemia: Sex Differences Administrative SupplementR01HL127113 · NHLBI · STANFORD UNIVERSITY · PI HUANG, NGAN F. · 2016 to 2020
$2.5M
NHLBI NIH HHS R01 HL127113
6 · The paper itself

Abstract

Secondary lymphedema is a common disorder associated with acquired functional impairment of the lymphatic system. The goal of this study was to evaluate the therapeutic efficacy of aligned nanofibrillar collagen scaffolds (BioBridge) positioned across the area of lymphatic obstruction in guiding lymphatic regeneration. In a porcine model of acquired lymphedema, animals were treated with BioBridge scaffolds, alone or in conjunction with autologous lymph node transfer as a source of endogenous lymphatic growth factor. They were compared with a surgical control group and a second control group in which the implanted BioBridge was supplemented with exogenous vascular endothelial growth factor-C (VEGF-C). Three months after implantation, immunofluorescence staining of lymphatic vessels demonstrated a significant increase in lymphatic collectors within close proximity to the scaffolds. To quantify the functional impact of scaffold implantation, bioimpedance was used as an early indicator of extracellular fluid accumulation. In comparison to the levels prior to implantation, the bioimpedance ratio was significantly improved only in the experimental BioBridge recipients with or without lymph node transfer, suggesting restoration of functional lymphatic drainage. These results further correlated with quantifiable lymphatic collectors, as visualized by contrast-enhanced computed tomography. They demonstrate the therapeutic potential of BioBridge scaffolds in secondary lymphedema.

Indexed as

LymphangiogenesisAnimalsCollagenFemaleLymphedemaNanofibersSwineSwine, MiniatureTissue ScaffoldsVascular Endothelial Growth Factor CCollagenVascular Endothelial Growth Factor CLymphangiogenesisLymphatic CT-imagingLymphatic vessel regenerationLymphedemaLymph node transplantationNanofibrillar collagen scaffoldPorcine lymphedema modelVEGF-C

Identifiers

PMID27348849
PMCPMC5157930
OpenAlexW2417772282

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.